Unit
Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin
AIM · Dept. I
Vitamin D deficiency is highly prevalent in malnourished inpatients and associated with higher mortality: A prospective cohort study
Merker M, Henzen C, Thomann R, Rutishauser J, Aujesky D, Rodondi N, Donzé J, Stanga Z, Mueller B, Brändle M, Sigrist S, Amsler A, Pereira R, Bolliger R, Tribolet P, Braun N, Hoess C, Pavlicek V, Bilz S, Schuetz P. Vitamin D deficiency is highly prevalent in malnourished inpatients and associated with higher mortality: A prospective cohort study. Medicine (Baltimore) 2019; 98:e18113.
Nov 1, 2019Vitamin D deficiency is highly prevalent in malnourished inpatients and associated with higher mortality: A prospective cohort study
Nov 1, 2019Medicine (Baltimore) 2019; 98:e18113
Merker Meret, Henzen Christoph, Thomann Robert, Rutishauser Jonas, Aujesky Drahomir, Rodondi Nicolas, Donzé Jaques, Stanga Zeno, Mueller Beat, Brändle Michael, Sigrist Sarah, Amsler Aline, Pereira Renata, Bolliger Rebekka, Tribolet Pascal, Braun Nina, Hoess Claus, Pavlicek Vojtech, Bilz Stefan, Schuetz Philipp
Distinct mechanisms of hypoglycaemia in patients with somatostatin-secreting neuroendocrine tumours
Wiesli P, Pavlicek V, Brändle M, Pfammatter T, Perren A, Schmid C. Distinct mechanisms of hypoglycaemia in patients with somatostatin-secreting neuroendocrine tumours. Endocrinol Diabetes Metab 2019; 2:e00083.
Jun 27, 2019Distinct mechanisms of hypoglycaemia in patients with somatostatin-secreting neuroendocrine tumours
Jun 27, 2019Endocrinol Diabetes Metab 2019; 2:e00083
Wiesli Peter, Pavlicek Vojtech, Brändle Michael, Pfammatter Thomas, Perren Aurel, Schmid Christoph
Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial
Schuetz P, Brändle M, Benz C, Henzen C, Mattmann S, Thomann R, Brand C, Rutishauser J, Aujesky D, Rodondi N, Donzé J, Stanga Z, Sigrist S, Bilz S, Schmid S, Fehr R, Baechli V, Geiser M, Deiss M, Gomes F, Kutz A, Tribolet P, Bregenzer T, Braun N, Hoess C, Pavlicek V, Mueller B. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet 2019; 393:2312-2321.
Apr 25, 2019Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial
Apr 25, 2019Lancet 2019; 393:2312-2321
Schuetz Philipp, Brändle Michael, Benz Carmen, Henzen Christoph, Mattmann Silvia, Thomann Robert, Brand Claudia, Rutishauser Jonas, Aujesky Drahomir, Rodondi Nicolas, Donzé Jacques, Stanga Zeno, Sigrist Sarah, Bilz Stefan, Schmid Sarah, Fehr Rebecca, Baechli Valerie, Geiser Martina, Deiss Manuela, Gomes Filomena, Kutz Alexander, Tribolet Pascal, Bregenzer Thomas, Braun Nina, Hoess Claus, Pavlicek Vojtech, Mueller Beat
Brain abscess caused by Cladophialophora bantiana: Total remission after full resection and short-course Voriconazole treatment
Baerlocher L. Brain abscess caused by Cladophialophora bantiana: Total remission after full resection and short-course Voriconazole treatment. Med Mycol Case Rep 2019; 2019 Mar; 23: 43–45.
Mar 1, 2019Brain abscess caused by Cladophialophora bantiana: Total remission after full resection and short-course Voriconazole treatment
Mar 1, 2019Med Mycol Case Rep 2019; 2019 Mar; 23: 43–45.
Baerlocher Lorenz
Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing Cholangitis.
Jung F, Cazzagon N, Vettorazzi E, Corpechot C, Chazouillères O, Arrivé L, Lohse A, Schramm C, Ehlken H. Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol 2019; 17:2613-2615.
Jan 4, 2019Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing Cholangitis.
Jan 4, 2019Clin Gastroenterol Hepatol 2019; 17:2613-2615
Jung Franziska, Cazzagon Nora, Vettorazzi Eik, Corpechot Christophe, Chazouillères Olivier, Arrivé Lionel, Lohse Ansgar W, Schramm Christoph, Ehlken Hanno
[Rapid Resolution of Symptomatic Hypercalcaemia]
Koster M, Ritter S, Brändle M. [Rapid Resolution of Symptomatic Hypercalcaemia]. Praxis (Bern 1994) 2019; 108:495-498.
Jan 1, 2019[Rapid Resolution of Symptomatic Hypercalcaemia]
Jan 1, 2019Praxis (Bern 1994) 2019; 108:495-498
Koster Markus, Ritter Simon, Brändle Michael
Vitamin-D-Intoxikation als seltene Ursache einer schweren Hyperkalzämie
Beglinger C, Kim M, Tsinalis D, Enzler-Tschudy A, Jung K, Brändle M, Binet F. Vitamin-D-Intoxikation als seltene Ursache einer schweren Hyperkalzämie - Wenn YouTube alles besser weiss …. Swiss Med Forum 2018; 18:796-799.
Nov 1, 2018Vitamin-D-Intoxikation als seltene Ursache einer schweren Hyperkalzämie
Nov 1, 2018Swiss Med Forum 2018; 18:796-799
Beglinger Catherine, Kim Min Jeong, Tsinalis Dimitrios, Enzler-Tschudy Annette, Jung Karin, Brändle Michael, Binet Françoise-Isabelle
[Diagnosis and Treatment of Familial Hypercholesterolemia]
Schöb M, Müller P, Gerth Y, Korte W, Rickli H, Brändle M, Bärlocher A, Bilz S. [Diagnosis and Treatment of Familial Hypercholesterolemia]. Praxis (Bern 1994) 2018; 107:1345-1353.
Nov 1, 2018[Diagnosis and Treatment of Familial Hypercholesterolemia]
Nov 1, 2018Praxis (Bern 1994) 2018; 107:1345-1353
Schöb Manuela, Müller Pascal, Gerth Yannick, Korte Wolfgang, Rickli Hans, Brändle Michael, Bärlocher Andreas, Bilz Stefan
Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.
Peiseler M, Reiners D, Pinnschmidt H, Sebode M, Jung F, Hartl J, Zenouzi R, Ehlken H, Groth S, Schachschal G, Rösch T, Weiler-Normann C, Lohse A, Schramm C. Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis. PloS one 2018; 13:e0202686.
Aug 20, 2018Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.
Aug 20, 2018PloS one 2018; 13:e0202686
Peiseler Moritz, Reiners David, Pinnschmidt Hans O, Sebode Marcial, Jung Franziska, Hartl Johannes, Zenouzi Roman, Ehlken Hanno, Groth Stefan, Schachschal Guido, Rösch Thomas, Weiler-Normann Christina, Lohse Ansgar W, Schramm Christoph
HbA and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Danne T, Sawhney S, Peters A, McGuire D, Lapuerta P, Kushner J, Franek E, Brath H, Brändle M, Banks P, Cariou B, Strumph P. HbA and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study. Diabetes care 2018; 41:1981-1990.
Jun 24, 2018HbA and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Jun 24, 2018Diabetes care 2018; 41:1981-1990
Danne Thomas, Sawhney Sangeeta, Peters Anne L, McGuire Darren K, Lapuerta Pablo, Kushner Jake A, Franek Edward, Brath Helmut, Brändle Michael, Banks Phillip, Cariou Bertrand, Strumph Paul
What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?
Herman W, Braffett B, Kuo S, Lee J, Brändle M, Jacobson A, Prosser L, Lachin J. What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?. J Diabetes Complicat 2018; 32:911-915.
Jun 12, 2018What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?
Jun 12, 2018J Diabetes Complicat 2018; 32:911-915
Herman William H, Braffett Barbara H, Kuo Shihchen, Lee Joyce M, Brändle Michael, Jacobson Alan M, Prosser Lisa A, Lachin John M
The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC)
Herman W, Braffett B, Kuo S, Lee J, Brändle M, Jacobson A, Prosser L, Lachin J. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC). J Diabetes Complicat 2018; 32:934-939.
Jun 12, 2018The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC)
Jun 12, 2018J Diabetes Complicat 2018; 32:934-939
Herman William H, Braffett Barbara H, Kuo Shihchen, Lee Joyce M, Brändle Michael, Jacobson Alan M, Prosser Lisa A, Lachin John M
An uncommon reason for weight loss
Wassmer P (2018). An uncommon reason for weight loss.
May 30, 2018An uncommon reason for weight loss
May 30, 2018SGAIM Frühjahrskongress 2018
Wassmer Philipp
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge
Palmer A, Gahn J, Valentine W, Pollock R, Breeze P, Brennan A, Pollard D, Ye W, Herman W, Isaman D, Kuo S, Laiteerapong N, Tran-Duy A, Smolen H, Brändle M, Si L, Tew M, Hua X, Willis M, Asseburg C, McEwan P, Leal J, Gray A, Foos V, Lamotte M, Feenstra T, O'Connor P, Clarke P. Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge. Value Health 2018; 21:724-731.
Apr 9, 2018Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge
Apr 9, 2018Value Health 2018; 21:724-731
Palmer Andrew J, Gahn James C, Valentine William J, Pollock Richard F, Breeze Penny, Brennan Alan, Pollard Daniel, Ye Wen, Herman William H, Isaman Deanna J, Kuo Shihchen, Laiteerapong Neda, Tran-Duy An, Smolen Harry J, Brändle Michael, Si Lei, Tew Michelle, Hua Xinyang, Willis Michael S, Asseburg Christian, McEwan Phil, Leal José, Gray Alastair, Foos Volker, Lamotte Mark, Feenstra Talitha, O'Connor Patrick J, Clarke Philip M
Fieber bei monoklonaler Gammopathie und Immunneuropathie – ein differenzialdiagnostischer Sple(e)n
Lüscher D, Diethelm M, Hundsberger T, Hitz F. Fieber bei monoklonaler Gammopathie und Immunneuropathie – ein differenzialdiagnostischer Sple(e)n. Praxis (Bern 1994) 2018; 107:329-333.
Mar 14, 2018Fieber bei monoklonaler Gammopathie und Immunneuropathie – ein differenzialdiagnostischer Sple(e)n
Mar 14, 2018Praxis (Bern 1994) 2018; 107:329-333
Lüscher Daniel, Diethelm Markus, Hundsberger Thomas, Hitz Felicitas
Compliance with guidelines for disease management in diabetes: results from the SwissDiab Registry
Schimke K, Renström F, Meier S, Stettler C, Brändle M, SwissDiab Study Group. Compliance with guidelines for disease management in diabetes: results from the SwissDiab Registry. BMJ Open Diabetes Res Care 2018; 6:e000454.
Feb 21, 2018Compliance with guidelines for disease management in diabetes: results from the SwissDiab Registry
Feb 21, 2018BMJ Open Diabetes Res Care 2018; 6:e000454
Schimke Katrin-Elisabeth, Renström Frida, Meier Sandro, Stettler Christoph, Brändle Michael, SwissDiab Study Group
missense mutation causes familial insulinomatosis and diabetes mellitus
Iacovazzo D, Jenni S, Sipos B, Nieser M, Frilling A, Dhatariya K, Chanson P, de Herder W, Konukiewitz B, Klöppel G, Stein R, Korbonits M, Christ E, Niederle B, Flanagan S, Walker E, Quezado R, de Sousa Barros F, Caswell R, Johnson M, Wakeling M, Brändle M, Guo M, Dang M, Gabrovska P, Ellard S. missense mutation causes familial insulinomatosis and diabetes mellitus. Proc Natl Acad Sci USA 2018; 115:1027-1032.
Jan 16, 2018missense mutation causes familial insulinomatosis and diabetes mellitus
Jan 16, 2018Proc Natl Acad Sci USA 2018; 115:1027-1032
Iacovazzo Donato, Jenni Stefan, Sipos Bence, Nieser Maike, Frilling Andrea, Dhatariya Ketan, Chanson Philippe, de Herder Wouter W, Konukiewitz Björn, Klöppel Günter, Stein Roland, Korbonits Márta, Christ Emanuel, Niederle Bruno, Flanagan Sarah E, Walker Emily, Quezado Rosana, de Sousa Barros Fernando Antonio, Caswell Richard, Johnson Matthew B, Wakeling Matthew, Brändle Michael, Guo Min, Dang Mary N, Gabrovska Plamena, Ellard Sian
[A Rare Differential Diagnosis of Chronic Cough]
Dicker M, Schneider T, von Kempis J, Diethelm M. [A Rare Differential Diagnosis of Chronic Cough]. Dtsch Med Wochenschr 2017; 142:1751-1755.
Nov 16, 2017[A Rare Differential Diagnosis of Chronic Cough]
Nov 16, 2017Dtsch Med Wochenschr 2017; 142:1751-1755
Dicker Michael, Schneider Tino, von Kempis Johannes, Diethelm Markus
Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly
Quarella M, Walser D, Brändle M, Fournier J, Bilz S. Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly. J Clin Endocrinol Metab 2017; 102:1451-1453.
Nov 1, 2017Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly
Nov 1, 2017J Clin Endocrinol Metab 2017; 102:1451-1453
Quarella Marino, Walser Daniel, Brändle Michael, Fournier Jean-Yves, Bilz Stefan
Blutdruck und akutes Koronarsyndrom – Pathophysiologie, Prognose und Therapie
Brenner R, Diethelm M, Maeder M. Blutdruck und akutes Koronarsyndrom – Pathophysiologie, Prognose und Therapie. LEADING OPTIONS Innere Medizin 2017; 2017:18-20.
Oct 11, 2017Blutdruck und akutes Koronarsyndrom – Pathophysiologie, Prognose und Therapie
Oct 11, 2017LEADING OPTIONS Innere Medizin 2017; 2017:18-20
Brenner Roman, Diethelm Markus, Maeder Micha